SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Jun 6 11:01 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe who wrote (2221)3/25/1999 8:14:00 AM
From: Duke  Read Replies (1) of 4140
 
Hello Joe,

I found your perspective both enjoyable and productive. Nice contribution to this board.

One correction if I may, the FDA panel meeting will not happen until Aug.

IMHO Regardless if the All Mighty attends the ASCRS and puts his rubber stamp on SNRS....the FDA panel is still....3...long....months thereafter.

nasd.com
confirms the short interest report schedule.

nasd.com
for the short interest post, Mar-25 report will clarify the change in SNRS short interest.

If the number of shares short has decreased from the previous month, I am apt to lean in the direction of your post. If the short interest is about the same, or has increased, the 8 1/2 - 10 trading range, which fits SNRS for the past month, and in conjunction to the FDA panel meeting in Aug. has me leaning for the price range to stay put.

Finally - I simply don't see institutional investors risking capital until the FDA stamp of approval. Not in this market. Ultimately with the FDA Approval Stamp, SNRS @ $20 is a price they can justify.

Like I said: IMHO

I hope I am proved wrong and the stock soars to $14 1/4. The 1/4 would rep a new high!

Again, appreciate your perspective,

Regards,

Duke
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext